Maxim Global Berhad (KLSE:MAXIM)

Inozyme Pharma Ratios and Metrics

Market cap in millions MYR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	261	221	276	238	294	426
Market Cap Growth	-33.33%	-20.00%	15.81%	-19.15%	-30.88%	81.25%
Enterprise Value	550	254	232	292	214	391
Last Close Price	0.35	0.30	0.37	0.35	0.41	0.58
PE Ratio	9.28	8.20	51.81	7.15	10.46	-
Forward PE	-	92.79	92.79	92.79	92.79	92.79
PS Ratio	0.74	0.67	2.36	0.68	0.81	1.09
PB Ratio	0.44	0.38	0.53	0.48	0.66	0.99
P/TBV Ratio	0.50	0.43	0.56	0.51	0.66	0.99
P/FCF Ratio	-	-	-	3.71	-	-
P/OCF Ratio	-	-	-	3.66	-	-
EV/Sales Ratio	1.56	0.77	1.98	0.83	0.59	1.00
EV/EBITDA Ratio	8.81	4.50	27.33	5.85	5.75	5.25
EV/EBIT Ratio	8.92	4.56	30.10	5.93	5.85	5.56
EV/FCF Ratio	-1.92	-	-	4.54	-	-
Debt / Equity Ratio	0.51	0.55	0.27	0.31	0.32	0.08
Debt / EBITDA Ratio	4.86	5.72	16.85	3.09	3.86	0.46
Debt / FCF Ratio	-	-	-	2.40	-	-
Asset Turnover	0.37	0.35	0.15	0.43	0.42	0.53
Inventory Turnover	0.55	0.52	0.30	1.01	1.10	2.00
Quick Ratio	2.44	2.31	2.65	4.29	1.55	1.41
Current Ratio	7.47	6.65	5.49	6.72	2.84	2.11
Return on Equity (ROE)	7.35%	6.99%	1.62%	7.68%	6.26%	-19.03%
Return on Assets (ROA)	4.08%	3.66%	0.61%	3.75%	2.63%	5.97%
Return on Capital (ROIC)	4.88%	4.43%	0.73%	4.98%	4.33%	9.66%
Return on Capital Employed (ROCE)	6.70%	6.00%	1.10%	7.60%	6.10%	14.00%
Earnings Yield	10.77%	12.20%	1.93%	14.00%	9.56%	-19.43%
FCF Yield	-109.64%	-132.71%	-2.54%	26.98%	-10.92%	-21.95%
Dividend Yield	2.82%	3.33%	5.46%	5.67%	4.82%	-
Payout Ratio	26.14%	27.33%	276.33%	37.61%	44.52%	-
Buyback Yield / Dilution	-5.67%	-9.88%	-6.45%	0.00%	-46.31%	-9.06%
Total Shareholder Return	-2.85%	-6.55%	-0.99%	5.67%	-41.49%	-9.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.